Beruflich Dokumente
Kultur Dokumente
- Respiratory
RQ = 0.8 1.0
Physiologic?
Includes anatomic, but in theory, when there are unperfused
regions, as with a pulmonary embolism
Shunt
Regions of the lung that are perfused but not ventilated!
Key pt: regions with a high V/Q ratio cannot compensate for
regions with a low V/Q ratio b/c the high V/Q is normal!
V/Q mismatch
Shunt
Measured by DLCO
larger TLCs
Chronic bronchitis?
Emphysema?
Restrictive diseases?
smaller TLCs
Fibrosis?
Obesity?
FRC reduced
TLC reduced
RV is elevated
Mechanisms of Hypoxemia
Hypoventilation
V/Q Mismatch
Shunt
Low Inspired pO2
Plethysmography
Normal
WhatsAlveoli!
this?
Dilated bronchi
Bronchiectasis
Bronchiectasis
What is it?
A chronic dilation of bronchi or bronchioles secondary to
inflammation or obstruction
Pre-disposing syndromes?
Cystic fibrosis (CF)
Primary ciliary dyskinesia syndrome (Kartageners s.)
Radiology?
Airway dilation which extends to the periphery
Pathology?
Permanent dilation of bronchi
peri-bronchial inflammation and organization (fibrosis)
Can sometimes see mucopurulent debris in
bronchioles
Eosinophil
This is ASTHMA!!!!
Asthma
Curschmann Spirals mucus
casts
Asthma
Clinical:
Airway hyperresponsiveness
Triggers: antigens, exercise, drugs, infections, stress
Acute, usually reversible diffuse bronchial narrowing
Sxs: Wheezing, dyspnea
Radiology:
Pathology:
Edema
smooth muscle thickening
BM thickening
mucous cell hyperplasia
increased submucosal eosinophils
thickened intralumenal mucus
Curschmann spirals mucus casts
Charcot-Leyden crystals eosinophil granule contents
Chronic Bronchitis
Increased numbers of mucinous glands in submucosa
A Clinical Diagnosis!
Radiology is non-specific
Pathology:
Mucous cellular and glandular
hyperplasia
May have submucosal chronic inflammation
May have respiratory bronchiolitis
Centrilobular
Emphysema in COPD
Emphysema
Clinical:
Associated with cigarette smoking (component of COPD)
1-antitrypsin deficiency, esp PIZZ mutation
Radiology:
Increased lucency (dark region)
Upper>lower lobe suggests centrilobular type
Lower>upper lobe suggests panlobular type
Pathology:
Dilation of distal airspaces with septal destruction
Locations:
Centrilobular: Cigarette smoke
Panlobular: A1AT deficiency or cigarette smoke
Bronchiolitis Obliterans/Organizing
Pneumonia (BOOP)
Clinical:
Acute onset cough, dyspnea, fever, and malaise
Multiple associations, e.g. collagen-vascular dz
Most patients respond to corticosteroids
Radiology:
Multiple patchy airspace infiltrates
Pathology:
Patchy fibromyxoid plugs in distal bronchioles the
BO
Fibromyxoid plugs in alveoli, +/- endogenous lipid
pneumonia the OP
Think bronchiolar and alveolar airspace fibroblasts
Classification of Asthma
Intrinsic Asthma No allergic or (personal
family) history
Usually adult onset
Often follows severe
respiratory illness
Symptoms usually
perennial
More refractory to
treatment, become other
diseases, progress to
vasculitis
Eosinophils still impt
What is AM dipping?
1.
Findings/Diagnosing
Asthma?
Spirometry
Increase lung volumes (TLC, FRC, RV)
Decreased peak flow, FVC, FEV1, FEV1/FVC
2.
3.
4.
Methacholine challenge
Hyper-responsive
5.
b-agonist
Reversible airflow obstruction when treated; albuterol
6.
Eosinophils
Increased in blood and found in sputum
7.
ABG
Low PO2, low PCO2
Treatment of Asthma
Avoid asthmatic triggers
Use bronchodilators
Sympathomimetics usually B2-AR specific to increase
cAMP.
albuterol
Salmeterol is a long acting B2
Infrequent attacks?
More frequent?
Add an anti-inflammatory as maintenance, usually a
corticosteroid
Significant attack?
Systemic steroids
Status asthmaticus?
IV corticosteroids
Aggressive bronchodilators
Classification of asthma?
Mild intermittent
Mild persistent more than 2X/week, but <1QD
Moderate persistent daily symptoms
Severe persistent continual symptoms
Inhaled irritants
Respiratory tract infections
Exercise (cool air)
Cough
Dyspnea
Wheezing airflow through narrowed airways
Chest tightness
Feature
Pink Puffer
Blue Bloater
Pathophys.
Type A
Type B
Disease
Association
Emphysema
Chronic Bronchitis
Major Sxs
Dyspnea
Appearance
Thin, wasted
Cyantoic, obese
PO2
Decreased
Decreased
PCO2
Normal or
decreased
Normal or
increased
Elastic recoil
Decreased
Normal
DLCO
Decreased
Normal
Hematocrit
Normal
Increased
Treatment of COPD
Bronchodilators
Antibiotics
Corticosteroids
Supplemental O2
Exercise rehab
Chest PT, postural drainage
Surgery (last resort)
Lung transplant
Lung volume reduction
Bupropion SR
Nicotine gum
Nicotine inhaler
Nicotine nasal spray
Nicotine patch
Peribronchovascular space
Is dilated
Giant cell
What disease?
Sarcoidosis
Clinical:
o
o
o
Sarcoidosis
Radiology:
o
Pathology:
o
o
Loose
Granulomas
Hypersensitivity
Pneumonia
Interstitial expansion
Peri-Bronchiolar
Expansion
Hypersensitivity Pneumonitis
(Extrinsic Allergic Alveolitis)
Clinical:
o
Organic dusts
o
o
Radiology:
o
Pathology:
o
Coal-workers Pneumoconiosis
Ferruginous Body
Asbestosis
Fibrotic Nodules
Late Silicosis
UIP
Clinical:
o
o
Radiology:
o
Pathology:
o
o
o
Alveolus
Proliferative (Organizing)
Phase Diffuse Alveolar
Damage (DAD)
Clinical:
o
o
o
> 1-2 wks after identifiable acute lung injury (ex: MVA, septic
shock, kidney stone, inhalation of noxious chemical)
Decreased pulm compliance -> mechanical ventilation
50% mortality
Radiology:
o
Pathology:
o
o
TLC
FRC
RV
TLC
FRC
RV
RV
IPF/UIP
Sarcoidosis
BOOP
Goodpastures
Wegeners
And many more (Connective tissue disease associated, Chronic eosinophilic
pneumonia, Lymphangioleiomyomatosis, Pulmonary Langerhans cell
histiocytosis, Alveolar proteinosis, Pulmonary vasculitides)
Pathophysiology of
Parenchymal Lung Diseases
Decreased lung compliance (increased stiffness)
o
o
Diffusion impairment
o
Pulmonary Hypertension
o
o
Hypoxemia
Obliteration of small pulmonary vessels by fibrosis
Clinical Features of
Parenchymal Lung Diseases
Symptoms
o
o
Dyspnea
Cough (non-productive)
Signs
o
o
o
JVD
Loud P2, TR murmer
edema
Macrophages
Lofgrens
Acute onset
Bilateral hilar lymphadenopathy
Eythema nodosum
Fever
Arthralgias
Associated with a good prognosis
Eye manifestations
Lupus pernio
o
o
o
o
o
o
o
Systemic corticosteroids
anti-TNF may be best tx (infliximab)
hydroxychloroquine
Stage I adenopathy
Stage II parenchymal infiltrates & adenopathy
Stage III just parenchymal infiltrates
Stave IV fibrosis, hilar retractionm, cysts, bullae, honeycombing
changes
UIP/IPF
Pathogenesis?
o
Cytokines
Chemokines
Matrix metallic proteases and balance with inhibitors
Decreased fibrinolysis
Eicosanoid imbalance: increased luekotrienes, decreased prostaglandins
Honeycombing
Diffuse reticulations
NO hilar enlargement
HRCT
Pathology of UIP?
o
o
o
Honeycombing
Fibrosis
Temporal heterogeneity
Secretory Inflammation
Hyperreactive Airways
Chronically
Nodular fibrosis
Coal macules
Silica collagenous lamellated nodules
Beryllium Granulomata
Diffuse Fibrosis
Asbestosis
Cancer
Asbestos
Chloromethyl Ether, Coke oven emissions
Silicosis
Asbestosis
Berylliosis
Coal Workers
Non-Malignant
A. Pleural Disease
1. Pleural Effusion
2. Diffuse Pleural Thickening
3. Localized Pleural Thickening (Plaques)
II.
B. Bronchogenic Carcinoma
C. Possibly Laryngeal Carcinoma
20-30days
Pathologic features?
o
o
o
o
Ferruginous bodies!
Peri-bronchiolar inflammation and fibrosis
May eventually honeycomb
Tendency towards the lower lobes of the lungs
Dyspnea on exertion
Dry cough
Late inspiratory crackles in bases
Opacification in bases
Pleural thickening
Occupational Asthma
Definition?
o
Risk factors?
Types of presentations:
o
o
o
o
Typical immediate onset w/in 30 minutes; clears hrs after leaving work. AM
cough & sputum. Responds to bronchodilators
Typical late onset may not have wheezing; 4-8hrs afterwards with longer
duration. Refractory to bronchodilators
Dual Response
Recurrent Attacks Post Exposure at night after exposure
Standard Treatment:
o
Pleural Diseases
What is pleuritic pain?
o
o
o
o
Pneumothorax disease
b/c its a popped lung, the pneumothorax is limited and should spontaneously resolve
20 y o severe asthmatic
Intubated & on mechanical ventilation
Suddenly becomes hypotensive & cyanotic
On side of pneumothorax
Its a dark and stormy night And a patient is brought into your
ER with:
After youre told hes NOT possessed and isnt just freaked out
after watching that scary movie, you get a CXR.
That CXR shows:
Thoracentesis
Helpful diagnostically
Helps relieve symptoms
Remove 1500cc or less!
Helpful diagnostically
Helps relieve symptoms
Remove 1500cc or less!
o
o
cell count & differential, glucose, cytology, Gram stain, AFB stain
& culture, amylase, cholesterol, triglyceride level, pH, adenosine
deaminase
o
o
o
o
Malignancy
Trauma - hemothorax
Empyema bacterial infections
Chylothorax disruption of thoracic duct
Rarely, TB
Cancer
Pulmonary infarction
Penetrating & nonpenetrating trauma
Central line malplacement
Chondrosarcoma
S/P CABG
Chylothorax
Empyema
>50% lymphocytes!
Remember, mesothelial cells are normally found in pleural fluid to some degree
since they are the cells that comprise the pleura!
Empyemas
Why should you distinguish between an empyema and a
parapneumonic effusion?
o
Gross pus
pH < 7.1
glucose < 40
positive Gram stain or cultures
Yeah RIP off that clot and scar tissue that I wish you saw
STOP!
Hamartoma!
Hamartoma
o
o
Its BENIGN!!!!
Clin:
Rad:
Adolescence adulthood
None in newborns - not congenital
Solitary nodule +/- popcorn calcification
Peripheral > central
Path:
Desmosomes
Keratin
Smokers association?
Prevalence?
YES
20-30% of common carcinomas
Radiology:
o
Path:
o
Primary
Gland formation
Adenocarcinoma
Pleural effusion
Mucin production (red on PASd stain)
Adenocarcinoma
Clin:
o
o
Rad:
o
Path:
o +/- glands
o +/- mucin
o
Bronchiolo-alveolar carcinoma
- Note the mucin in the alveoli. Gas exchange is gonna suck in this patient!
Bronchioloalveolar
carcinoma (BAC)
Subset of?
o
Adenocarcinoma
Incidence?
o
o
Rad:
o
Path:
o
o
o
Clin:
10% of common carcinomas
Rad:
non-specific
Path:
H&E: Undifferentiated
cDNA microarrays: distinct disease
Basically,
Necrotic
carcinoma
Viable carcinoma
Normal lymphocytes
At diagnosis
Response to therapy
Smokers?
o
o
20 % of common carcinomas
Paraneoplastic Syndromes:
o
o
YES
Rad:
o
o
Central in >90%
Frequent metastases to LNs and distant sites
Path:
o
o
Visible
CP
Angle
Mesothelioma
LossofCPAngle
Normalthicknesspleura
Thickenedpleura
=Pleuraleffusionormass
Breast adenoCA
GI adenoCA
Renal adenoCA
Head/neck squamous cell CA
Genetics
Smoking (15% smokers will get lung cancer; 85% CA in smokers)
Polycyclic hydrocarbons
WOMEN
Differences in metabolism, CYP450
Hormonal effects in lungs
3p NSCLC
Ras adenocarcinoma
Myc small cell
NSCLC p53
Rb small cell
Random breaks in 1, 3, 5, 7, 15, 17
Liver
Bone
Brain
Adrenals
Staging Lung CA
SCLC
o
Whats Useful?
T location, size
N nodes
M metastases
-
Intrathoracic
Chest CT
FDG PET Scan
Mediastinoscopy
Extrathoracic
Bone scan
CT/MRI of brain
Abdominal CT (liver, adrenals)
Biopsies of extrathoracic lesions
Treating NSCLC
o
o
o
Treating SCLC
o
o
Adenocarcinoma
Bronchioloalveolar carcinoma
Subtype of adenocarcinoma
More common in women
More common in non-smokers than smokers for poorly defined
reasons
Cough and bronchorrhea (frothy sputum production)
Variable radiographic presentation: solitary nodule, multiple
nodules, infiltrate/consolidation with air-bronchograms
Exclusively in smokers
Generally arise in proximal airways
May cause obstruction of the airway with distal atelectasis, post obstructive
pneumonia
May cavitate
Hypercalcemia due to PTH like substance (weakness, dehydration, mental
status changes), clubbing
Time to Take a
Study Break!!!
Is it close to midnight?
Types of inflammatory
responses/cells in infections and
likely disease process
Neutrophils
Acute pneumonia (usually bacterial)
Usually in alveoli
Lymphocytes
Usually viral or atypical pneumonia
Usually in interstitium
Granulomatous inflammation (epitheloid
histiocytes, lymphocytes, giant cells)
Usually mycobacterial or fungal pneumonia
Giant Celll
Early: pulmonary edema and proliferation of bacteria, intraalveolar accumulation of neutrophils and erythrocytes (red
hepatization)
Later: serum and fibrinous exudates, intra-alveolar organization,
macrophages (gray hepatization)
Pyothorax/empyema
Infection of pleural fluid with purulent material within the pleural
space.
May become loculated (fibrous walls around the inflammation),
which requires drainage as well as antibiotics to treat.
Bacteremia
Bacteria within the bloodstream
May seed distant sites
Endocarditis, meningitis, pericarditis
An abscess.
Whos likely to get it and
where?
Granulomatous inflammation
In hilar lymph node
Positive AFB
Tuberculosis
Primary tuberculosis
Secondary tuberculosis
Complications of tuberculosis
Miliary Tb
Multiple small (millet seed size) granulomas in many organs
Results from hematogenous dissemination
Kidneys, adrenals, bone marrow, spleen, liver lymph nodes are
common sites
Hemoptysis
Erosion of inflammatory response/Tb granuloma into a
pulmonary artery
Bronchopleural fistula
Erosion of inflammatory response/granuloma into the pleural
space, resulting in Tb empyema
Unusual complications you cough up Tb and swallow it, and its
happy to colonize somewhere else
Tuberculous laryngitis
Intestinal tuberculosis
Mycobacterium avium-intracellulare
Mycobacterium kansasii
Associated with Hairy cell leukemia
Mycobacterium bovis
Infection from ingested milk (the bow Tb)
Histoplasmosis
Found in:
in infected dust, bird droppings
Appearance:
dimorphic fungus with tiny yeast forms
Common location:
Endemic in midwest and southeast US, particularly Mississippi and
Ohio valleys
Coccidioidomysis
Appearance:
dimorphic fungi with large thick walled sporangia 30-60
microns filled with endospores 1-5 microns
Geography/location:
Endemic in southwestern US, particularly San Joaquin
valley.
Cryptococcosis
Appearance?
yeast 4-9 microns with mucinous capsule
Found in?
pigeon droppings
Clinical and pathological presentation?
Clinical disease almost exclusively in immunocompromised
patients
Lung is the portal of entry
CNS is the most common symptomatic site (especially
cryptococcal meningitis)
Organism may be demonstrated in CSF, lung washings/BAL
and biopsy with special stains (India Ink, mucin stains).
Cryptococcus is one of the few fungi with mucicarmine
positive capsule.
Cryptococcus: mucicarmine positive capsule
Cryptococcus on GMS stain showing narrow based budding
Blastomycosis
Appearance:
a large dimorphic fungus with broad based budding.
Geography/location:
In US in Mississipi and Ohio River valleys and Great
Lakes regions
Pathology:
Disease usually confined to lungs, causes mixed
granulomatous and suppurative inflammation
Aspergillosis
Appearance:
septate hyphae with acute angle branching, found in soil and decaying
plant material
Diseases/Presentation
Aspergilloma (Mycetoma, fungus ball)
Aspergilloma
showing
non-invasive
fungus
within granulation
tissue line
Aspergilloma
(fungus
ball) within
pre-existing
cavity
cavity
Aspergillus within
blood vessel wall
Invasive aspergillus
Mucormycosis (Zygomycosis)
Caused by inhalation of spores of several fungi
(Mucor, Rhizopus, Absidia) ubiquitous in soil,
food, decaying vegetable material
Appearance?
grow as non-septate hyphae
Common patients?
patients with underlying illness, particularly diabetics
Common presentation?
rhinocerebral (nasal sinuses and brain) and
pulmonary. Causes vascular invasion, septic
infaction, hemorrhage
Mucomycosis
Pneumocystis carinii
What is it?
A common pulmonary pathogen causing pneumonia in
immunosuppressed patients, especially HIV
Viral pneumonias
Cytomegalovirus most common viral infxn
Interstitial pneumonia in infants and immunocompromised
patients, especially organ transplant patients, now we screen
(donor & recipient)
Large cell, big nucleus w/ large, single basophilic
intranuclear inclusion
Measles
Multinucleated giant cells with nuclear inclusions
Cytomegalovirus pneumonia
Viral inclusion
Herpes virus on cytology specimen
Mycoplasma
Small free-living prokaryote, common cause of acute selflimited pneumonia and tracheobronchitis,
milder than usual bacterial pneumonia (walking
pneumonia)
Highly transmissible through airborne droplets
Cause of 15-20% of pneumonias in developed countries
Pathology: patchy consolidation, mononuclear
infiltrate, usually of a lower lobe
Very common but not very bad
Youll see something on CXR but not lots of sxs
Really common at college/in dorms
MECHANICAL (INNATE)
IMMUNE
GENERAL
Lysozymes
IgA neutralizing; secreted as a dimer
IgG opsonizing
What are the defenses in the alveoli/distal airways?
No cilia or mucus
Macrophages they can seek and phagocytose pathogens, as well
as coordinated the cellular response via chemotactic factors and
cytokines
IgG
Inhalation
Hematogenous
Atypical Pneumonia
Indolent onset (7-10days)
Less ill appearing
Low-grade fever, malaise,
headache, dry cough
Rales without consolidation
Mild/no leukocytosis;
negative cultures
Patchy/interstitial infiltrates
on CXR
Meant to describe:
Mycoplasma, or Chlamydia
Sputum Grams stain and culture: used but utility debated due
to high false+ and false- rates
Blood cultures: for hospitalized patients (specific, but not
sensitive); much better.
Yeeeeeeeearrrrrrhhhhh!!!
(yes I know Im a dork, but youre laughing admit it.
And I have to entertain myself SOMEHOW!)
Clinical course:
Exposure history:
Outdoorsman (Blastomycosis)
Desert southwest (Coccidioidomycosis)
TB contacts or from endemic area
Demographics:
Clinical findings:
CXR:
multilobar involvement,
fulminant progression
Aerobic GN bacilli
like Klebsiella
Anaerobes
H. influenzae
COPD, smoker
S. aureus
P. aeruginosa
DRSP
No underlying. disease or
modifying factors
2.
Underlying comorbidities
or modifying factors
(COPD, CHF, alcoholism,
)
Inpatient
3.
Outpatient: With
Cardiopulmonary
Disease/Modifying Risk Factors
IV antipneumococcal fluoroquinolone
IV 3rd generation cephalosporin + macrolide
OR
OR
IV antipneumococcal fluoroquinolone
Consider Vancomycin (MRSA and PRSP)
If there is a Pseudomonas risk, add these:
Anti-pseudomonal B-lactam + cipro
Common pathogens:
P. aeruginosa,
Enterobacter,
E. coli,
Klebsiella,
Proteus,
Serratia,
S. aureus,
Acinetobacter,
anaerobes
Diagnosis
Visualization (DFA, silver stain) of organisms in lower
resp. secretions (induced sputum; bronchoalveolar
lavage 85-95% sensitive in HIV)
Treatment:
Trimethoprim-Sulfamethoxazole (Bactrim)
IV pentamidine
Corticosteroids: for pO2 < 70 mmHg or A-a grad >35
mmHg (reduces risk of resp. failure and death)
Histoplasmosis, Coccidiodomycosis:
Usually disseminated disease in HIV
Invasive Aspergillosis:
Airway obstruction
Periodic hemoptysis
May be massive, as source is hypertrophied bronchial
arteries, which are at system blood pressure
Immunoglobulin deficiency:
IgG/subclasses, IgA
PCD:
1-antitrypsin
ABPA:
-agonists
Surgery
Cystic Fibrosis
What are the major defects?
Production of thick, tenacious secretions from exocrine glands
Elevated concentrations of Na2+, K+, and Cl- in sweat
CFTR malfxn:
Sweat Chloride Test gold standard; > 60 mmol/L
CFTR Mutation Analysis genotyping; 2 mutations required
Nasal Potential Difference (PD) testing demonstrates ion transport
abnormalities
Phenotypic features:
Chronic Sinopulmonary Disease:
GI:
Others:
Airway clearance
DNase, mucolytics
Hypertonic saline speeds up clearance of mucus
Bronchodilators
Infection
Inflammation
Ibuprofen
Corticosteroids
Azithromycin also an antibiotic! Shown to slow disease
Nutritional Support
Occluded artery
Parenchymal infarct
with hemorrhage
Pulmonary Thromboembolism
Pulmonary Thromboemboli
(pulmonary embolism, PE)
Clinical:
Dyspnea, hemoptysis
Commonly due to lower extremity thrombi
Radiology:
Decreased flow, V/Q mismatch abnormal V/Q
scan
Pathology:
Pulmonary arterial thromboemboli
Survivors may have peripheral wedge-shaped
infarction
Radiology:
Non-specific
Pathology:
Medial hypertrophy
intimal proliferation
intimal fibrosis
plexiform vascular lesions
Necrotizing
Granulomatous
Vasculitis
Wegeners Granulomatosis
Vascular Changes
Intimal proliferation
Medial hypertrophy
Angiomatoid transformation
Fibrinoid necrosis
Hyperkinetic:
Occlusive:
Chronic PE
Obliterative:
Vasoconstrictive:
hypoxia, scleroderma
PGIS,
endothelin,
Kv-channels,
eNOS,
mutant BMPR2,
ANP
Symptoms of PPH
Progressive exertional dyspneavirtually 100%
Fatigue
Chest paindue to right ventricular
Ischemia
Exercise syncope or near syncope
Hemoptysis
Hoarseness
Peripheral edema
Therapy of Pulmonary
Hypertension
Anticoagulation improves survival
Oxygen in hypoxemic patients
Ca2+ channel blockers may improve exercise tolerance
and hemodynamics in patients (~25%) with mildmoderate disease
Prostacyclinintravenous/subcutaneous
administration improves hemodynamics, exercise
tolerance, and prolongs survival in severe PPH
Bosentanendothelin receptor antagonist that
improves exercise tolerance.
Transplantation the last resort
Hemodynamic consequences
Decrease in x-section area of pulmonary vascular bed:
Venography
Impedance Plethysmography
Duplex Scanning
Dopper flow velocity
MRI scans
Symptoms
Signs
Tachycardia
Increased P2
Thrombophlebitis in lower extremeties
S3,S4 gallop
Diaphoresis
Edema
Murmur
Cyanosis
Laboratory Studies
Dyspnea
Pleuritic pain
Apprehension
Cough
Hemoptysis
Syncope
ECG- non-specific, sign of Right heart strain S1Q3 pattern in precordial leads
CXR
Blood Gases
D-Dimers more useful to r/o
Absolute:
Recent (w/in two weeks) hemorrhagic CVA.
Recent neurosurgery, ocular or spinal surgery
Relative:
Radiology:
Diffuse alveolar filling pattern
Pathology:
Endo- or epithelial injury, Type II cell hyperplasia
First 2 wks after injury: edema fibrin
Prematurity
Tachypnea, intercostal muscle retraction,
hypoxemia
Radiology:
Pathology:
RBCs filling
alveolar spaces
Causes of
Alveolar Hemorrhage Syndrome
Goodpastures syndrome
Acute lupus pneumonitis
Wegeners granulomatosis
Goodpastures syndrome
Clinical:
Young adults, M>F
Radiology:
Diffuse alveolar pattern
Pathology:
Anti-basement membrane IgG antibodies
damage pulmonary and renal basement
membranes
Linear IgG and C deposition by
ImmunoFluorescence and Electron microscopy
Anti-GBM IgG is detectable in serum
Radiology:
Diffuse alveolar pattern
Pathology:
Necrotizing capillaritis due to immune complexes
Granular IgG/C deposition by IF and EM
ANA or anti-dsDNA Ab detectable in serum
Lipid
Aspiration of cooked fat
Aspiration
Clinical:
Radiology:
Pathology:
Clinical:
Radiology:
Pathology:
Foamy
Macrophages
Capillary congestion
Pulmonary Edema
Clinical:
Cardiogenic: LV pump failure, mitral valve
stenosis
Radiology:
Incr. vascular markings, reticular +/- nodular
Think Kerley B lines
Pathology:
Venous and capillary congestion
Incr. free water in the interstitium +/- alveoli
Define ARDS
Acute Respiratory Distress Syndrome
A clinical definition
Acute onset
Bilateral infiltrates on CXR
Pulmonary Artery wedge pressure <18 or no evidence of left atrial
hypertension
PaO2/FIO2 < 300: Acute Lung Injury
PaO2/FIO2 < 200: ARDS
Septic Shock
Inflammatory Cytokines
Nitric Oxide from Vasc. Endothelium
Low Systemic Vascular Resistance
High Cardiac Output Hypotension
Wide pulse pressure ex: (90/30)
Hyperdynamic
Lactic Acidosis
b/c all these tissues are underperfused
Fever,
tachypnea,
tachycardia,
Leukocytosis
Be careful; there are some infections that resemble sepsis but ARENT despite the
overlap with SIRS
It all comes down to is it multiorgan?!?!
Sepsis
Severe Sepsis
Septic shock
Infection plus
2 SIRS criteria
Sepsis
Organ dysfunction (ex: hypotension, hypoxemia)
Sepsis
Hypotension despite fluid resuscitation
Altered organ function in an acutely ill patient
Homeostasis cannot be maintained without intervention
Persistent hypoxemia
Increased alveolar dead space
Further decrease in compliance
Pulmonary hypertension - Obliteration of pulmonary capillary bed
2 General Classes of
Respiratory Failure
Hypoxemic - inadequate O2 delivery
Hypercapnic - respiratory acidosis (high PCO2)
secondary to failure to adequately ventilate
Hypoxemic Failure
Physiological Causes
A. Decreased PIO2
B. Decreased VA
C. Ventilation/Perfusion [V/Q] Mismatch
D. RL Shunt
E. Diffusion Limitation only problematic during exercise
Decreased VA
Hypoxia (PAO2) secondary from hypercapnia (PACO2)
V/Q Mismatch
Can be corrected by supplemental O2
RL Shunt
Refractory to O2 treatment
Diffusion Limitation
Only a problem under exercise stress due to increased
CO (common in pulmonary fibrosis)
Increased VE 2o VCO2
Increased VE 2o VD/VT
Decreased VA
fever, trauma
pCO2 HCO3-
7.40
40
24
Normal
7.30
55
26
Acute Failure
7.37
55
31
Compensated Failure
7.25
85
36
Clinical signs of
respiratory muscle weakness
1. Tachypnea
2. Decreasing Vital Capacity
3. Decreasing Maximum Inspiratory Force
4. Ineffective cough
Note: Hypercapnea is a late sign of respiratory failure
due to neuromuscular limitations.
C. Assist devices
1. Negative pressure - Iron lung, Cuirass ventilator
2. Nasal/Face Mask CPAP - Continuous Positive Airway Pressure
3. Cycled CPAP (BiPAP) - Bilevel Positive Airway Pressure
Forebrain
Hypothalamus
Central reflex hypernea
Pons
Apneustic breathing pause btw inspiration and expiration
Cluster breathing
Ataxic breathing
Medullary
Ondines Curse no involuntary control of breathing
Ataxic breathing
Central
There is no stimulus to breath
Relaxation of lower airway muscles
Associated w/:
Snoring
Obesity (can still occur in normal body habitus)
Mixed w/ Cheyne-Stokes or hypoventilation
HTN
Tachycardia
Narrow airway, edema, large neck
Risk factors: smoking, alcohol, GERD, brain disease, heart disease, ADHD (any kid who
snores, evaluate!)
IS a risk factor for: HTN, MI, Stroke, RHF, pulmonary HTN, Diabetes, Motor vehicle
accidents, HA, Depression, Shorter life span by 7-10yrs
OSA Treatment
Respiratory Failure
Lung Failure
Gas Exchange Failure
Hypoxemia
Low Inspired O2
Diffusion Limit
Shunt
Poor VA
VQ Mismatch
Ventilation Failure
Hypercapnia
CNS Depression
Muscular Fatigue
Mechanical Failure
Causes of Hypercapnic
Failure
Normal Ventilation
Increased Production of CO2 (fever,
tramua)
Normal Ventilation with Increased
Deadspace (VQ Mismatch)
Pulmonary Embolus
Emphysema
Decreased Ventilation (lots of causes)
Breath Holding
Obesity
Drugs
Abnormal perception/psychogenic
Congrats!
Youre
Done!
Good luck on the exam
&